CLINICAL-TRIALS OF WR-2721 PRIOR TO ALKYLATING AGENT CHEMOTHERAPY AND RADIOTHERAPY

被引：63

作者：

GLOVER, D

FOX, KR

WEILER, C

KLIGERMAN, MM

TURRISI, A

GLICK, JH

机构：

[1] UNIV PENN,DEPT RADIAT THERAPY,PHILADELPHIA,PA 19104

[2] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104

来源：

关键词：

D O I：

10.1016/0163-7258(88)90032-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：3 / 7

页数：5

共 28 条

[21] WASSERMAN TH, 1981, CANCER CLIN TRIALS, V4, P3
[22] WEISMAN RA, 1985, ABSTR AM AC OT HEAD
[23] EFFICACY TESTING OF WR-2721 IN GREAT-BRITAIN OR EVERYTHING IS BLACK AND WHITE AT THE GRAY LAB
YUHAS, JM
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (04): : 595 - 598
[24] YUHAS JM, 1969, J NATL CANCER I, V42, P331
[25] YUHAS JM, 1980, CANCER TREAT REP, V64, P57
[26] YUHAS JM, 1980, CANCER RES, V40, P1519
[27] CIRCUMVENTION OF THE TUMOR MEMBRANE BARRIER TO WR-2721 ABSORPTION BY REDUCTION OF DRUG HYDROPHILICITY
YUHAS, JM
DAVIS, ME
GLOVER, D
BROWN, DQ
RITTER, M
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4): : 519 - 522
[28] Yuhas JMS, 1980, RAD SENSITIZERS, P303